Clinical Trial
Published on 19 Feb 2026
Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression
in Mood Disorders
- 213 views
Clinical Trial
Published on 19 Feb 2026
in Mood Disorders
Original Research
Published on 19 Feb 2026
in Quantitative Psychology and Measurement
Original Research
Published on 19 Feb 2026
in Intensive Care Medicine and Anesthesiology
Review
Published on 19 Feb 2026
in Antibiotic Resistance and New Antimicrobial drugs
Original Research
Published on 19 Feb 2026
in Clinical Infectious Diseases
Original Research
Published on 19 Feb 2026
in Brain Health and Clinical Neuroscience
Original Research
Published on 19 Feb 2026
in General Cardiovascular Medicine
Core Concept
Published on 19 Feb 2026
in Engineering and Technology
Original Research
Published on 19 Feb 2026
in Biosafety and Biosecurity
Review
Published on 19 Feb 2026
in Microbial Symbioses
Original Research
Published on 19 Feb 2026
in Antimicrobials, Resistance and Chemotherapy
Review
Accepted on 18 Feb 2026
in Alzheimer's Disease and Related Dementias
Original Research
Accepted on 18 Feb 2026
in Structural Materials
Original Research
Accepted on 18 Feb 2026
in Cancer Imaging and Image-directed Interventions
Original Research
Accepted on 18 Feb 2026
in Land, Livelihoods and Food Security
Original Research
Accepted on 18 Feb 2026
in Sports Coaching: Performance and Development